Atricure Inc. (ATRC)

Trade ATRC now with
9/30/2020 10:44:29 AM Stock Alert: AtriCure Loses 5%
5/11/2020 8:45:19 PM AtriCure Prices Public Offering Of 3.98 Mln Shares At $44.00/shr
5/11/2020 7:18:20 AM AtriCure Expects To Sell About $100 Mln Of Common Shares
5/8/2020 8:50:19 AM AtriCure Announces Results From CONVERGE IDE Clinical Trial
4/9/2020 8:11:04 AM AtriCure Exoects Q1 Preliminary Revenue To Be $53.2 Mln; Withdraws 2020 Outlook
8/13/2019 2:47:55 PM AtriCure Completes Acquisition Of SentreHEART
4/23/2019 8:04:59 AM AtriCure Announces First Patient Enrollment In The DEEP IDE Trial Restart
2/12/2019 8:02:17 AM AtriCure Announces Launch Of CryoICE CryoSPHERE Probe
2/5/2019 8:05:07 AM AtriCure Announces First Patient Enrolled In The ICE-AFIB Clinical Trial
10/3/2018 4:02:30 PM AtriCure Expects Q3 Revenue Of Approx. $49.9 Mln
10/3/2018 4:01:56 PM AtriCure Announces Proposed Public Offering Of Common Stock
8/28/2018 8:04:49 AM AtriCure Completes Patient Enrollment In The CONVERGE IDE Clinical Trial
7/24/2018 4:32:58 PM ViewRay Appoints Scott Drake As President, CEO And Director
6/5/2018 6:03:04 AM AtriCure Partners With Baheal In China To Distribute Surgical Ablation Devices
1/8/2018 8:20:59 AM AtriCure Expects Q4 Revenue To Be About $46.1 Mln,FY17 Revenue $174.7 Mln
9/12/2017 8:12:33 AM AtriCure Announces U.S. Launch Of The AtriClip PRO•V Device
7/18/2017 4:15:47 PM AtriCure Hires Salvatore Privitera As Its Chief Technology Officer